MarketBeat
IBEX Conference: Management Touts Organic Growth, Margin Gains, and AI-Powered BPO Upside
📈
AI Sentiment
Highly Positive
9/10
- Home
- IBEX
IBEX
IBEX Limited
as of 03-24-2026 3:55pm EST
$27.24
$1.50
-5.22%
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 383.7M | IPO Year: | 2017 |
| Target Price: | $35.00 | AVG Volume (30 days): | 95.9K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.65 | EPS Growth: | 28.26 |
| 52 Week Low/High: | $21.64 - $42.99 | Next Earning Date: | 05-07-2026 |
| Revenue: | $558,273,000 | Revenue Growth: | 9.77% |
| Revenue Growth (this year): | 13.14% | Revenue Growth (next year): | 5.67% |
| P/E Ratio: | 16.95 | Index: | N/A |
| Free Cash Flow: | 27.3M | FCF Growth: | +13.07% |
Stock Insider Trading Activity of IBEX Limited (IBEX)
Dechant Robert Thomas
Sell
Chief Executive Officer
IBEX Feb 23, 2026
Avg Cost/Share
$28.46
Shares
6,000
Total Value
$170,752.80
Owned After
275,406
SEC Form 4
Dechant Robert Thomas
Sell
Chief Executive Officer
IBEX Feb 20, 2026
Avg Cost/Share
$29.40
Shares
6,000
Total Value
$176,398.20
Owned After
275,406
SEC Form 4
Dechant Robert Thomas
Sell
Chief Executive Officer
IBEX Feb 19, 2026
Avg Cost/Share
$29.73
Shares
6,000
Total Value
$178,358.40
Owned After
275,406
SEC Form 4
Dechant Robert Thomas
Sell
Chief Executive Officer
IBEX Feb 18, 2026
Avg Cost/Share
$29.98
Shares
6,000
Total Value
$179,853.60
Owned After
275,406
SEC Form 4
Dechant Robert Thomas
Sell
Chief Executive Officer
IBEX Feb 17, 2026
Avg Cost/Share
$29.63
Shares
6,000
Total Value
$177,786.00
Owned After
275,406
SEC Form 4
Inson Paul Joseph
Sell
Chief People Officer
IBEX Feb 6, 2026
Avg Cost/Share
$34.98
Shares
2,627
Total Value
$91,892.46
Owned After
27,469
SEC Form 4
Darwal Michael Joseph
Sell
Chief AI & Digital Officer
IBEX Feb 6, 2026
Avg Cost/Share
$34.98
Shares
1,660
Total Value
$58,066.80
Owned After
42,185
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dechant Robert Thomas | IBEX | Chief Executive Officer | Feb 23, 2026 | Sell | $28.46 | 6,000 | $170,752.80 | 275,406 | |
| Dechant Robert Thomas | IBEX | Chief Executive Officer | Feb 20, 2026 | Sell | $29.40 | 6,000 | $176,398.20 | 275,406 | |
| Dechant Robert Thomas | IBEX | Chief Executive Officer | Feb 19, 2026 | Sell | $29.73 | 6,000 | $178,358.40 | 275,406 | |
| Dechant Robert Thomas | IBEX | Chief Executive Officer | Feb 18, 2026 | Sell | $29.98 | 6,000 | $179,853.60 | 275,406 | |
| Dechant Robert Thomas | IBEX | Chief Executive Officer | Feb 17, 2026 | Sell | $29.63 | 6,000 | $177,786.00 | 275,406 | |
| Inson Paul Joseph | IBEX | Chief People Officer | Feb 6, 2026 | Sell | $34.98 | 2,627 | $91,892.46 | 27,469 | |
| Darwal Michael Joseph | IBEX | Chief AI & Digital Officer | Feb 6, 2026 | Sell | $34.98 | 1,660 | $58,066.80 | 42,185 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 5, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLFeb 5, 2026 · 100% conf.
AI Prediction SELL
1D
-9.42%
$30.99
Act: +2.25%
5D
-8.60%
$31.27
Act: -12.89%
20D
-3.29%
$33.09
Act: -10.97%
Price: $34.21 Prob +5D: 0% AUC: 1.000
0001720420-26-000005
ibex-20260205FALSE000172042000017204202026-02-052026-02-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2026
IBEX Limited (Exact name of registrant as specified in its charter)
Bermuda001-3844200-0000000 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
1717 Pennsylvania Avenue NW, Suite 825 Washington, District of Columbia 20006 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (202) 580-6200 Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered Common shares, par value of $0.000111650536IBEXNasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition.
On February 5, 2026, IBEX Limited issued a press release announcing its financial results for its second fiscal quarter ended December 31, 2025.
A copy of the February 5, 2026 press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
The information in this Item 2.02, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Description 99.1 Press release announcing financial results for the second fiscal quarter ended December 31, 2025, dated February 5, 2026 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IBEX LIMITED
(Registrant)
Date: February 5, 2026 /s/ Taylor Greenwald (Signature) Name:Taylor Greenwald Title:Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 6, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 6, 2025
0001720420-25-000039
ibex-20251106FALSE000172042000017204202025-11-062025-11-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2025
IBEX Limited (Exact name of registrant as specified in its charter)
Bermuda001-3844200-0000000 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
1717 Pennsylvania Avenue NW, Suite 825 Washington, District of Columbia 20006 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (202) 580-6200 Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered Common shares, par value of $0.0001IBEXNasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition.
On November 6, 2025, IBEX Limited issued a press release announcing its financial results for its first fiscal quarter ended September 30, 2025.
A copy of the November 6, 2025 press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
The information in this Item 2.02, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Description 99.1 Press release announcing financial results for the first fiscal quarter ended September 30, 2025, dated November 6, 2025 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IBEX LIMITED
(Registrant)
Date: November 6, 2025 /s/ Taylor Greenwald (Signature) Name:Taylor Greenwald Title:Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Sep 11, 2025
2025
Q2
Q2 2025 Earnings
8-KSep 11, 2025
0001720420-25-000026
ibex-20250911FALSE000172042000017204202025-09-112025-09-11
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2025
IBEX Limited (Exact name of registrant as specified in its charter)
Bermuda001-3844200-0000000 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
1717 Pennsylvania Avenue NW, Suite 825 Washington, District of Columbia 20006 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (202) 580-6200 Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered Common shares, par value of $0.0001IBEXNasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company x If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition.
On September 11, 2025, IBEX Limited issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2025.
A copy of the press release is attached hereto as Exhibit 99.1 to this current report on Form 8-K.
The information in this Item 2.02, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Description 99.1 Press release announcing financial results for fourth quarter and fiscal year ended June 30, 2025, dated September 11, 2025 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IBEX LIMITED
(Registrant)
Date: September 11, 2025 /s/ Taylor Greenwald (Signature) Name:Taylor Greenwald Title:Chief Financial Officer
Latest IBEX Limited News
IBEX Breaking Stock News: Dive into IBEX Ticker-Specific Updates for Smart Investing
Compare IBEX vs Leading Stocks
See how IBEX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "IBEX IBEX Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.